Published in Medicine (Baltimore) on September 01, 1994
Problems for clinical judgement: 1. Eliciting an insightful history of present illness. CMAJ (2001) 1.81
Acromegaly. Orphanet J Rare Dis (2008) 1.61
Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol (2008) 1.15
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest (2004) 1.13
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) (2009) 1.11
Gene Expression Signature in Adipose Tissue of Acromegaly Patients. PLoS One (2015) 0.80
Mandibular prognathism caused by acromegaly - a surgical orthodontic case. Head Face Med (2009) 0.79
Nanomedicines in the treatment of acromegaly: focus on pegvisomant. Int J Nanomedicine (2006) 0.79
Two birds with one stone: octreotide treatment for acromegaly and breast cancer. J Clin Oncol (2013) 0.78
Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly. PLoS One (2013) 0.78
A rare case of gastric cancer in an acromegalic patient. J Gastroenterol (1997) 0.77
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel. Biologics (2008) 0.77
Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults. Clin Endocrinol (Oxf) (2009) 0.76
Surgical management of acromegaly in a resource-challenged environment. Niger Med J (2015) 0.75
Oral manifestations in growth hormone disorders. Indian J Endocrinol Metab (2012) 0.75
Implementing a screening program for acromegaly in Latin America: necessity versus feasibility. Pituitary (2016) 0.75
No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study). Medicine (Baltimore) (2016) 0.75
Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials. World J Gastroenterol (2005) 0.75
Detecting growth hormone misuse in athletes. Indian J Endocrinol Metab (2013) 0.75
Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients. Pituitary (2017) 0.75
Prevalence of acromegaly in patients with symptoms of sleep apnea. PLoS One (2017) 0.75
Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med (2001) 10.69
Shopping around for hospital services: a comparison of the United States and Canada. JAMA (1998) 4.41
Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol (1993) 4.39
Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med (1999) 3.49
Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev (1994) 2.96
The "metabolically-obese," normal-weight individual. Am J Clin Nutr (1981) 2.71
Primer on medical decision analysis: Part 1--Getting started. Med Decis Making (1997) 2.61
Food production and the energy crisis. Science (1973) 2.55
Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care (1987) 2.50
N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem J (1993) 2.36
Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech Ageing Dev (1994) 2.16
Decreased regional blood flow in patients with acromegaly. Clin Endocrinol (Oxf) (1998) 1.99
Conformation and dynamics of heparin and heparan sulfate. Glycobiology (2000) 1.88
Primer on medical decision analysis: Part 3--Estimating probabilities and utilities. Med Decis Making (1997) 1.84
Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys (1996) 1.70
Discharge after discharge: predicting surgical site infections after patients leave hospital. J Hosp Infect (2010) 1.63
Continuous electrocardiographic monitoring and cardiac arrest outcomes in 8,932 telemetry ward patients. Acad Emerg Med (2000) 1.60
Primer on medical decision analysis: Part 2--Building a tree. Med Decis Making (1997) 1.58
Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results. Med Decis Making (1997) 1.57
Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med (1997) 1.56
In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. Eur J Endocrinol (1995) 1.53
Problems for clinical judgement: 4. Surviving in the report card era. CMAJ (2001) 1.52
Emergency department overcrowding following systematic hospital restructuring: trends at twenty hospitals over ten years. Acad Emerg Med (2001) 1.48
Successful pregnancy in a previously infertile woman treated with SMS-201-995 for acromegaly. N Engl J Med (1989) 1.47
The glucose uptake of human adipose tissue in obesity. Eur J Clin Invest (1971) 1.44
Risk of premature stroke in recent immigrants (PRESARIO): population-based matched cohort study. Neurology (2010) 1.44
Measuring injury severity: time for a change? J Trauma (1998) 1.40
Sustained reduction of exercise perfusion defect extent and severity with isosorbide mononitrate (Imdur) as demonstrated by means of technetium 99m sestamibi. J Nucl Cardiol (2000) 1.40
Primer on medical decision analysis: Part 5--Working with Markov processes. Med Decis Making (1997) 1.39
Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes (1979) 1.33
Caloric restriction prevents age-associated accrual of oxidative damage to mouse skeletal muscle mitochondria. Free Radic Biol Med (1998) 1.32
[Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides]. Diabetologia (1969) 1.24
How reliable is peer review of scientific abstracts? Looking back at the 1991 Annual Meeting of the Society of General Internal Medicine. J Gen Intern Med (1993) 1.22
Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol (1999) 1.19
Prognostic indices in clinical practice. JAMA (2001) 1.18
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia (1977) 1.17
Car phones and car crashes: an ecologic analysis. Can J Public Health (1998) 1.16
Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly. Clin Endocrinol (Oxf) (2000) 1.15
Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group. J Clin Endocrinol Metab (1990) 1.15
Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest (2000) 1.14
Availability of antidotes at acute care hospitals in Ontario. CMAJ (2001) 1.14
Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol (1992) 1.14
Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radic Biol Med (1999) 1.13
Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int J Microcirc Clin Exp (1996) 1.12
Problems for clinical judgement: 3. Thinking clearly in an emergency. CMAJ (2001) 1.08
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab (2001) 1.07
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood (1987) 1.07
Long-term outcomes in open pelvic fractures. J Trauma (1997) 1.07
What is a good decision? Eff Clin Pract (1999) 1.05
Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours. Clin Pharmacokinet (1993) 1.04
How to read clinical journals: X. How to react when your colleagues haven't read a thing. CMAJ (2000) 1.04
Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut (1992) 1.02
Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med (1993) 1.02
Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci (1992) 1.02
Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology (Berl) (2001) 1.00
Effect of age and caloric restriction on bleomycin-chelatable and nonheme iron in different tissues of C57BL/6 mice. Free Radic Biol Med (1999) 0.99
Insulin secretion in relation to adipose tissue in men. Diabetes (1971) 0.99
The health of homeless immigrants. J Epidemiol Community Health (2009) 0.99
The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study. Carbohydr Res (1994) 0.98
Long-term outcomes in blunt trauma: who goes back to work? J Trauma (1997) 0.98
Effects of trauma cases on the care of patients who have chest pain in an emergency department. J Trauma (2000) 0.96
Exercise does not modify spatial memory, brain autoimmunity, or antibody response in aged F-344 rats. Neurobiol Aging (1991) 0.95
Sauna-induced acceleration in insulin absorption. Br Med J (1980) 0.94
The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly. Acta Endocrinol (Copenh) (1987) 0.93
A new sample-processing unit for the fluorescent microsphere method. Am J Physiol (1999) 0.93
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
Differential responsiveness to cocaine in C57BL/6J and DBA/2J mice. Psychopharmacology (Berl) (1998) 0.92
Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Clin Ther (2000) 0.92
Characterization and prevention of phototoxic effects in intravital fluorescence microscopy in the hamster dorsal skinfold model. Langenbecks Arch Surg (2000) 0.92
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. J Clin Endocrinol Metab (2000) 0.91
Adipose tissue cellularity in maturity onset diabetes mellitus. Acta Med Scand (1972) 0.90
Effect of physical training on glucose tolerance and on glucose metabolism of skeletal muscle in anaesthetized normal rats. Diabetologia (1979) 0.90
Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature. Neuroimmunomodulation (1998) 0.90
Determination of internal dynamics of deoxyriboses in the DNA hexamer d(CGTACG)2 by 1H NMR. Eur Biophys J (1989) 0.89
Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes (1982) 0.89
Effects of dextran on microvascular ischemia-reperfusion injury in striated muscle. Am J Physiol (1997) 0.88
The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM. Trent HCV Study Group. J Hepatol (1996) 0.88
Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles. Neuroimmunomodulation (1998) 0.88
In vivo monitoring of microvessels in skin flaps: introduction of a novel technique. Microsurgery (2001) 0.88
Dynamics of trimethoprim bound to dihydrofolate reductase. Proc Natl Acad Sci U S A (1988) 0.88
Enhancement of learning and memory in mice by a benzodiazepine antagonist. FASEB J (1988) 0.87
Obesity and hypertension. Mechanisms and implications for management. JAMA (1982) 0.87
Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med (1990) 0.87
Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr (1994) 0.87
Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients. J Clin Invest (1979) 0.87
Characteristics of patients with seasonal allergic rhinitis and concomitant asthma. Clin Exp Allergy (2004) 0.86
Acute and long-term outcomes of extremely injured blunt trauma victims. J Trauma (1995) 0.86
Economic methods for measuring the quality of life associated with HIV infection. Qual Life Res (1999) 0.86
Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. Proc Natl Acad Sci U S A (1989) 0.85
Spectroscopic studies of quinonoid species from pyridoxal 5'-phosphate. Biochemistry (1988) 0.85
Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy (1999) 0.85
Endoscopic sphincterotomy for common bile duct calculi in patients without stones in the gallbladder. Dig Dis Sci (1993) 0.84
Effect of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone on protein oxidation and life span. Arch Biochem Biophys (1995) 0.84
CGS 8216, a benzodiazepine receptor antagonist, enhances learning and memory in mice. Brain Res (1988) 0.84
Decision analysis with cumulative prospect theory. Med Decis Making (2001) 0.84
Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice. Behav Brain Res (2000) 0.83
Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol (1997) 0.83
Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer. Anticancer Res (1989) 0.83
Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects. Dig Dis Sci (1993) 0.82